Octagos Health Secures $43M to Power AI-Driven Cardiac Care
Summary
What You Should Know: Octagos Health, a provider of AI-powered cardiac device monitoring solutions raises $43M in Series B funding led by funds managed by Morgan Stanley Expansion Capital with continued participation from Mucker Capital and other strategic investors. The investment fuels Octagos Healths mission to leverage artificial intelligence for transformative cardiac care and comprehensive patient monitoring.Octagos Health offers a cutting-edge AI platform designed for continuous monitoring and in-depth data analysis of patients with implanted cardiac devices, including pacemakers, defibrillators, and more. Their proprietary technology, Atlas AI, boasts high accuracy and sensitivity in detecting critical cardiac events. Informed Decisions & Improved Outcomes: By providing data-driven insights, Atlas AI empowers healthcare providers to make informed decisions and ultimately improve patient outcomes.Octagos Healths platform offers a comprehensive suite of features designed for seamless integration into existing workflows: Customizable Reporting Features: Customizable reporting allows healthcare providers to tailor reports for optimal clinical decision-making.By combining AI, patient services, and bidirectional EHR integration, the Octagos Health platform enables cardiologists to efficiently monitor patients, improve patient care, and enhance clinic economics. The funding will help us accelerate our growth across the US and expand into other critical areas of cardiac care, including ambulatory monitors, consumer wearables, and sleep.